Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venous Thromboembolism Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT02945280
What this trial is testing

Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

Who this might be right for
Deep Venous ThrombosisUpper Extremity Deep Venous ThrombosisThrombus+2 more
Intermountain Health Care, Inc. 52
Not applicableStudy completedNCT04374617
What this trial is testing

Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19

Who this might be right for
COVID-19Critical IllnessVenous Thromboembolism+7 more
Hospital Universitari Vall d'Hebron Research Institute 230
Not applicableStudy completedNCT05643885
What this trial is testing

Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer

Who this might be right for
Thromboembolism
Pfizer 7,304
Testing effectiveness (Phase 2)Study completedNCT00331838
What this trial is testing

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

Who this might be right for
Venous Thromboembolism
Sanofi 705
Testing effectiveness (Phase 2)Study completedNCT02309411
What this trial is testing

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis

Who this might be right for
Venous Thromboembolism
Bayer 46
Not applicableUnknownNCT03405571
What this trial is testing

Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.

Who this might be right for
Multiple MyelomaVenous Thromboembolism
University of Athens 800
Not applicableUnknownNCT05993533
What this trial is testing

Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy

Who this might be right for
Venous Thromboembolic Disease
Direction Centrale du Service de Santé des Armées 100
Not applicableStudy completedNCT02095925
What this trial is testing

Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism

Who this might be right for
CancerDeep Venous ThrombosisPulmonary Embolism
Harry R. Buller 900
Not applicableStudy completedNCT01029743
What this trial is testing

Xarelto Regulatory Post-Marketing Surveillance

Who this might be right for
Venous Thromboembolism
Bayer 3,388
Large-scale testing (Phase 3)Study completedNCT05515120
What this trial is testing

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Who this might be right for
Venous ThromboembolismAnticoagulant-induced BleedingVenous Thromboses+1 more
Instituto Mexicano del Seguro Social 58
Not applicableUnknownNCT06416280
What this trial is testing

Inter-observer Reliability of the TRiP(Cast) Score in Patients With Trauma to a Lower Limb Requiring Immobilisation

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisPulmonary Embolism+3 more
University Hospital, Angers 302
Not applicableStudy completedNCT02870296
What this trial is testing

Anticoagulation Medical Home

Who this might be right for
Venous ThromboembolismPatient-Centered Care
University of Massachusetts, Worcester 162
Early research (Phase 1)Ended earlyNCT04022915
What this trial is testing

PET Fibrin Imaging of DVT and PE

Who this might be right for
Pulmonary EmbolismDeep Vein ThrombosisVenous Thromboembolism
Peter Caravan 6
Not applicableStudy completedNCT00063518
What this trial is testing

Monitoring Trends in Venous Thromboembolism

Who this might be right for
Blood Coagulation DisordersVenous ThromboembolismCardiovascular Diseases
University of Massachusetts, Worcester
Not applicableStudy completedNCT00683397
What this trial is testing

Frankfurt Thrombophilia Registry

Who this might be right for
Venous Thromboembolism
Cardioangiologisches Centrum Bethanien 2,000
Large-scale testing (Phase 3)Study completedNCT00135876
What this trial is testing

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Who this might be right for
Venous ThromboembolismBrain Tumors
Ontario Clinical Oncology Group (OCOG) 512
Not applicableStudy completedNCT00720915
What this trial is testing

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
McMaster University 410
Not applicableStudy completedNCT01984190
What this trial is testing

Multicenter Registry for Effectiveness Analysis of ActiveCare+S.F.T® Mobile Compression Device for Thrombosis Prevention in Hip and Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Medical Compression Systems 411
Not applicableStudy completedNCT01277536
What this trial is testing

Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland

Who this might be right for
Venous Thromboembolism
University Hospital, Geneva 1,478
Not applicableUnknownNCT01363193
What this trial is testing

Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients

Who this might be right for
ObesityMorbid ObesityVenous Thromboembolism+3 more
Nazareth Hospital 100
Next Page